LeonaBio (LONA) EPS (Diluted) (2021 - 2026)
LeonaBio (LONA) EPS (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.99 Bn | 132.14 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 86.80 Bn | 78.80 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 65.38 Bn | 60.19 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 60.70 Bn | 55.56 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.21 Bn | 26.37 Bn | - | 0.15 |
| 10 | LeonaBio | 186.16 Mn | 135.09 Mn | - | -0.82 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.11 |
| Dec 31, 2025 | -18.85 |
| Sep 30, 2025 | -1.99 |
| Jun 30, 2025 | -2.15 |
| Mar 31, 2025 | -2.76 |
| Dec 31, 2024 | -27.94 |
| Sep 30, 2024 | -8.07 |
| Jun 30, 2024 | -7.47 |
| Mar 31, 2024 | -7.67 |
| Dec 31, 2023 | -7.73 |
| Sep 30, 2023 | -9.72 |
| Jun 30, 2023 | -8.87 |
| Mar 31, 2023 | -8.42 |
| Dec 31, 2022 | -8.83 |
| Sep 30, 2022 | -7.02 |
| Jun 30, 2022 | -6.47 |
| Mar 31, 2022 | -8.92 |
| Dec 31, 2021 | -5.09 |
| Sep 30, 2021 | -6.39 |